CIPRA
Completed Trials:
Cipra Neurodevelopmental Substudy
The effects of early versus delayed antiretroviral treatment on the short and long – term neurodevelopment outcome of HIV – Infected children.
Duration: January 2006 – December 2011
Cipra Project 2 ( CHER) Trial
A Phase III, Randomized, Open-label trial to evaluate strategies for proving antiretroviral therapy to infants shortly after primary infection in a resource poor setting.
Duration: August 2005 – August 2011
Cipra Project 4 trial
An Evaluation of quantative and qualitative antibody response to Streptococcus pneumonia and Haemophilus Influenza Type b conjugate vaccines amongst HIV-1 – exposed – infected children that are receiving vs. those not receiving antiretroviral therapy, as well as among HIV-1 unexposed – uninfected children.
Duration: May 2005 – August 2011
Cipra Substudy
Association of Maternal Depression and Other Psychiatric Outcomes with Long-term Neurodevelopment in HIV – Positive Infants Receiving Early or Delayed Antiretroviral Treatment
Duration: January 2006 – June 2012
Current Trials:
R01 + R21
The effects of early versus delayed antiretroviral treatment on the short and long – term neurodevelopment outcome of HIV – Infected children.
Duration: September 2011 - ongoing
